Embecta Corp. investors who bought common stock between November 25, 2025 and May 4, 2026 have until August 17, 2026 to seek appointment as lead plaintiff in a securities class action already filed against the company, according to Rosen Law Firm. The complaint alleges defendants made false or misleading statements, or concealed material adverse facts, about Embecta's fiscal results, including that the company knew or recklessly disregarded that its guidance was misleading and unattainable, and that it described its pen needle business as "incredibly resolute" only weeks before missing expectations and cutting fiscal 2026 guidance. Rosen said investors may seek compensation through a contingency fee arrangement and noted that no class has been certified, so investors may retain their own counsel, remain absent class members, or do nothing at this stage. A newer topic provided with this record concerns Blaize Holdings, Inc., a different securities class action with a July 18, 2025 to April 28, 2026 class period and an October 5, 2026 lead plaintiff deadline, and does not match the Embecta event.